Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00319488 · ClinicalTrials.gov registry record · NA
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
A NA study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
- 238
- Enrollment target
NCT00319488 is a NA study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 238 participants.
The verdict
NCT00319488, a NA study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of initiating a high-dose inhaled corticosteroid (ICS) or a leukotriene receptor antagonist (LTRA) in addition to an inhaled beta2-agonist (albuterol) at the onset of respiratory tract illness (RTI)-associated symptoms in increasing episode-free days among young children with recurrent severe wheezing.
Interventions
- DRUG Inhaled Corticosteroid (Budesonide)
- DRUG Leukotriene Receptor Antagonist (Montelukast Sodium)
- DRUG Inhaled Albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2004-02 |
| Est. Completion | 2006-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00319488
The ClinicalTrials.gov registry entry for NCT00319488 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Inhaled Corticosteroid (Budesonide) is the first listed.
NCT00319488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00319488 about?
NCT00319488 is a clinical study titled "Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)". This study will determine the effectiveness of initiating a high-dose inhaled corticosteroid (ICS) or a leukotriene receptor antagonist (LTRA) in addition to an inhaled beta2-agonist (albuterol) at the onset of respiratory tract illness (RTI)-associated symptoms in increasing episode-free days among...
What is the current status of trial NCT00319488?
This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2004-02. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00319488?
The interventions under investigation include: Inhaled Corticosteroid (Budesonide) (DRUG), Leukotriene Receptor Antagonist (Montelukast Sodium) (DRUG), Inhaled Albuterol (DRUG).
Who is sponsoring clinical trial NCT00319488?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.